Kidney Function and Toxicity « « Myriad RBM
 
 

Bibliography

Kidney Function and Toxicity

2013

Urinary cystatin C as a renal biomarker and its immunohistochemical localization in anti-GBM glomerulonephritis rats (2013) Togashi Y, Imura N, Miyamoto Y Exp Toxicol Pathol. 2013 Jun 20. pii: S0940-2993(13)00076-6
 
Product Associations
 
 
Therapy Indications
 

Allogeneic mesenchymal stem cell infusion for the stabilization of focal segmental glomerulosclerosis (2013) Mirco Belingheri, Lorenza Lazzari, Valentina Parazzi, Elena Groppali, Ettore Biagi, Giuseppe Gaipa, Rosaria Giordano, Maria Pia Rastaldi, Daniela Croci, Andrea Biondi, Paolo Rebulla, Alberto Edefonti, Luciana Ghio Biologicals, Available online 14 October 2013
 
Product Associations
 
 
Therapy Indications
 

Allogeneic mesenchymal stem cell infusion for the stabilization of focal segmental glomerulosclerosis (2013) Belingheri M, Lazzari L, Parazzi V, Groppali E, Biagi E, Gaipa G, Giordano R, Rastaldi MP, Croci D, Biondi A, Rebulla P, Edefonti A, Ghio L Biologicals. 2013 Oct 14. pii: S1045-1056(13)00111-5. doi: 10.1016/j.biologicals.2013.09.004

EFFECTS OF CONTRAST MEDIA ON DIFFERENT URINARY BIOMARKERS OF KIDNEY INJURY (2013) Jürgen Steffgen, Sabine Blaschke, Niko Brun-Schulte-Wissing, Philipp Pagel, Fritz Huber, James Mapes, Astrid Jaehnige and Sabine Pestel Nephrol. Dial. Transplant. (2013) 28 (suppl 1): i331-i351.
 
Product Associations
 
 
Therapy Indications
 

Back To Top

2012

Effects of Stimulation of Soluble Guanylate Cyclase on Diabetic Nephropathy in Diabetic eNOS Knockout Mice on Top of Angiotensin II Receptor Blockade (2012) Ott IM, Alter ML, von Websky K, Kretschmer A, Tsuprykov O, Sharkovska Y, Krause-Relle K, Raila J, Henze A, Stasch JP, Hocher B PLoS One. 2012;7(8):e42623. Epub 2012 Aug 10

DPP-4 Inhibition on Top of Angiotensin Receptor Blockade Offers a New Therapeutic Approach for Diabetic Nephropathy (2012) Altera ML, Ottb IM, von Webskyb K, Tsuprykovb O, Sharkovska Y, Krause-Relle K, Raila, J, Henze A, Klein T, Hocher B Kidney Blood Press Res 2012;36:119-130
 
Therapy Indications
 

Association of Estimated Glomerular Filtration Rate and Urinary Uromodulin Concentrations with Rare Variants Identified by UMOD Gene Region Sequencing (2012) Köttgen A, Yang Q, Shimmin LC, Tin A, Schaeffer C, Coresh J, Liu X, Rampoldi L, Hwang S, Boerwinkle E, Hixson JE, Linda Kao WH, Fox CS PLoS ONE 7(5): e38311
 
Therapy Indications
 

Early Urinary and Plasma Biomarkers for Experimental Diabetic Nephropathy (2012) Alter ML, Kretschmer A, Von Websky K, Tsuprykov O, Reichetzeder C, Simon A, JP Stasch, Hoche B Clin. Lab. 2012;58:659-671
 
Product Associations
 
 
Therapy Indications
 

Urinary cystatin C as a biomarker for diabetic nephropathy and its immunohistochemical localization in kidney in Zucker diabetic fatty (ZDF) rats (2012) Togashi Y, Miyamoto Y Exp Toxicol Pathol. 2012 Jul 11
 
Product Associations
 
 
Therapy Indications
 

Toxicity Profile of Small-Molecule IAP Antagonist GDC-0152 is Linked to TNF-Alpha Pharmacology (2012) Erickson RI, Tarrant J, Cain G, Lewin-Koh SC, Dybdal N, Wong H, Blackwood E, West K, Steigerwalt R, Mamounas M, Flygare JA, Amemiya K, Dambach D, Fairbrother WJ, Diaz D Toxicol Sci. 2012 Sep 5. [Epub ahead of print]
 
Therapy Indications
 

Mapping creatinine- and cystatin C-related white matter brain deficits in the elderly (2012) Rajagopalan P, Refsum H, Hua X, Toga AW, Jack CR Jr, Weiner MW, Thompson PM; Alzheimer's Disease Neuroimaging Initiative Neurobiol Aging. 2012 Nov 19. pii: S0197-4580(12)00533-7
 
 

Back To Top

2011

The Role of Residual Gadolinium in the Induction of Nephrogenic Systemic Fibrosis-Like Skin Lesions in Rats (2011) Pietsch H, Raschke M, Ellinger-Ziegelbauer H, Jost G, Walter J, Frenzel T, Lenhard D, Hütter J, Sieber MA Invest Radiol. 46: 48-56.
 
Therapy Indications
 

Pharmacological inhibition of myostatin suppresses systemic inflammation and muscle atrophy in mice with chronic kidney disease (2011) Zhang L, Rajan V, Lin E, Hu Z, Han HQ, Zhou X, Song Y, Min H, Wang X, Du J, Mitch WE FASEB J. 2011 May;25(5):1653-63

Intratracheal instillation of cerium oxide nanoparticles induces hepatic toxicity in male Sprague-Dawley rats (2011) Nalabotu SK, Kolli MB, Triest WE, Ma JY, Manne NDPK, Katta A, Addagarla HS, Rice KM, Blough ER International Journal of Nanomedicine Volume 2011:6 Pages 2327 - 2335
 
Therapy Indications
 

Urinary cystatin C as a biomarker for acute kidney injury and its immunohistochemical localization in kidney in the CDDP-treated rats (2011) Togashi Y, Sakaguchi Y, Miyamoto M, Miyamoto Y Exp Toxicol Pathol. 2011 Mar 4. [Epub ahead of print]
 
Product Associations
 
 
Therapy Indications
 

Assessment of Biomarkers of Drug-induced Kidney Injury in Cynomolgus Monkeys Treated with a Triple Re-uptake Inhibitor (2011) Guha M, Heier A, Price S, Bielenstein M, Caccese RG, Heathcote DI, Simpson TR, Stong DB, Bodes E Toxicol Sci. 2011 Jan 22. [Epub ahead of print]
 
Product Associations
 
 
Therapy Indications
 

Clinical and Plasma Proteomic Markers Correlating With Chronic Kidney Disease After Liver Transplantation (2011) Levitsky J, Salomon DR, Abecassis M, Langfelder P, Horvath S, Friedewald J, Wang E, Kurian SM, Mondala T, Gil S, McDade R, Ballard K, Gallon L Am J Transplant. 2011 Jul 27.

Comparison of the course of biomarker changes and kidney injury in a rat model of drug-induced acute kidney injury (2011) Sasaki D, Yamada A, Umeno H, Kurihara H, Nakatsuji S, Fujihira S, Tsubota K, Ono M, Moriguchi A, Watanabe K, Seki J Biomarkers. 2011 Sep 28. [Epub ahead of print]
 
Product Associations
 
 
Therapy Indications
 

Biomarkers for drug-induced renal damage and nephrotoxicity-an overview for applied toxicology (2011) Fuchs TC, Hewitt P AAPS J. 2011 Dec;13(4):615-31
 
Therapy Indications
 

Trefoil Factor 3 Predicts Incident Chronic Kidney Disease: A Case-Control Study Nested within the Atherosclerosis Risk in Communities (ARIC) Study (2011) Astor BC, Köttgen A, Hwang SJ, Bhavsar N, Fox CS, Coresh J Am J Nephrol. 2011 Aug 9;34(4):291-297.
 
Therapy Indications
 

Urinary biomarkers in hexachloro-1:3-butadiene-induced acute kidney injury in the female Hanover Wistar rat; correlation of a-glutathione S-transferase, albumin and kidney injury molecule-1 with histopathology and gene expression (2011) Swain A, Turton J, Scudamore CL, Pereira I, Viswanathan N, Smyth R, Munday M, McClure F, Gandhi M, Sondh S, York M J Appl Toxicol. [Epub ahead of print]
 
Therapy Indications
 

Lower urinary connective tissue growth factor levels and incident CKD stage 3 in the general population (2011) O'Seaghdha CM, Hwang SJ, Bhavsar NA, Köttgen A, Coresh J, Astor BC, Fox CS Am J Kidney Dis. 2011 Jun;57(6):841-9
 
Therapy Indications
 

Back To Top

2010

Recommendations to qualify biomarker candidates of drug-induced liver injury (2010) Ozer JS, Chetty R, Kenna G, Koppiker N, Karamjeet P, Li D, Palandra J, Lanevschi A, Souberbielle BE, Ramaiah S Biomark Med 4: 475-483.
 
Therapy Indications
 

A panel of urinary biomarkers to monitor reversibility of renal injury and a serum marker with improved potential to assess renal function (2010) Ozer JS, Dieterle F, Troth S, Perentes E, Cordier A, Verdes P, Staedtler F, Mahl A, Grenet O, Roth DR, Wahl D, Legay F, Holder D, Erdos Z, Vlasakova K, Jin H, Yu Y, Muniappa N, Forest T, Clouse HK, Reynolds S, Bailey WJ, Thudium DT, Topper MJ, Skopek TR, Sina JF, Glaab WE, Vonderscher J, Maurer G, Chibout SD, Sistare FD, Gerhold DL Nat Biotechnol.28: 444-5.
 
Therapy Indications
 

A guidance for renal biomarker lead optimization and use in translational pharmacodynamics (2010) Ozer JS Drug Discov Today15: 142-7.
 
Therapy Indications
 

Urinary clusterin, cystatin C, ß2-microglobulin and total protein as markers to detect drug-induced kidney injury (2010) Dieterle F, Perentes E, Cordier A, Roth DR, Verdes P, Grenet O, Pantano S, Moulin P, Wahl D, Mahl A, End P, Staedtler F, Legay F, Carl K, Laurie D, Chibout SD, Vonderscher J, Maurer G Nat Biotechnol 28: 463-469.
 
Therapy Indications
 

Kidney injury molecule-1 outperforms traditional biomarkers of kidney injury in preclinical biomarker qualification studies (2010) Vaidya VS, Ozer JS, Dieterle F, Collings FB, Ramirez V, Troth S, Muniappa N, Thudium D, Gerhold D, Holder DJ, Bobadilla NA, Marrer E, Perentes E, Cordier A, Vonderscher J, Maurer G, Goering PL, Sistare FD, Bonventre JV Nat Biotechnol. 28: 478-85.
 
Therapy Indications
 

Uromodulin levels associate with a common UMOD variant and risk for incident CKD (2010) Köttgen A, Hwang SJ, Larson MG, Van Eyk JE, Fu Q, Benjamin EJ, Dehghan A, Glazer NL, Kao WH, Harris TB, Gudnason V, Shlipak MG, Yang Q, Coresh J, Levy D, Fox CS J Am Soc Nephrol 21: 337-344.
 
Therapy Indications
 

Back To Top

2009

Distinct functions of activated protein C differentially attenuate acute kidney injury (2009) Gupta A, Gerlitz B, Richardson MA, Bull C, Berg DT, Syed S, Galbreath EJ, Swanson BA, Jones BE, Grinnell BW J Am Soc Nephrol. 20: 267-77.
 
Therapy Indications
 

The Liver Toxicity Biomarker Study: Phase I Design and Preliminary Results. (2009) McBurney RN, Hines WM, Von Tungeln LS, Schnackenberg LK, Beger RD, Moland CL, Han T, Fuscoe JC, Chang CW, Chen JJ, Su Z, Fan XH, Tong W, Booth SA, Balasubramanian R, Courchesne PL, Campbell JM, Graber A, Guo Y, Juhasz PJ, Li TY, Lynch MD, Morel NM, Plasterer TN, Takach EJ, Zeng C, Beland FA Toxicol Pathol 37: 52-64.
 
Therapy Indications
 

The involvement of pro-inflammatory cytokines in nephrogenic systemic fibrosis - a mechanistic hypothesis based on preclinical results from a rat model treated with gadodiamide. (2009) Steger-Hartmann T, Raschke M, Riefke B, Pietsch H, Sieber MA, Walter J Exp Toxicol Pathol 61: 537-552.

Analysis of Renal Biomarkers in Samples of Rat Urine Samples Frozen for 44 months From a Study on Puromycin Amino Nucleoside (PAN) (2009) Perron MF, Burnett R, Reiniche A, Briffaux JP, Eisinger D, Küsters S and Mapes J Toxicology LettersVolume 189, Supplement 1, S159
 
Therapy Indications
 

Back To Top

2008

Tissue distribution and toxicity of intravenously administered titanium dioxide nanoparticles in rats. (2008) Fabian E, Landsiedel R, Ma-Hock L, Wiench K, Wohlleben W, van Ravenzwaay B Arch Toxicol 82: 151-157.

Endothelial activation markers in anemic non-dialysis chronic kidney disease patients. (2008) Patel TV, Mittal BV, Keithi-Reddy SR, Duffield JS, Singh AK Nephron Clin Pract 110: c244-250.

Back To Top

2007

Activated protein C ameliorates LPS-induced acute kidney injury and downregulates renal INOS and angiotensin 2. (2007) Gupta A, Rhodes GJ, Berg DT, Gerlitz B, Molitoris BA, Grinnell BW Am J Physiol Renal Physiol 293: F245-F254.
 
Therapy Indications
 

Role of protein C in renal dysfunction after polymicrobial sepsis (2007) Gupta A, Berg DT, Gerlitz B, Sharma GR, Syed S, Richardson MA, Sandusky G, Heuer JG, Galbreath EJ, Grinnell BW J Am Soc Nephrol. 2007 Mar;18(3):860-7
 
Therapy Indications